Structural Summit 2024: Disruptive Innovations, Complex Interventions

An event of great significance for interventional cardiology in South America is coming soon: the Structural Summit 2024, organized jointly by the Brazilian Society of Hemodynamics and Interventional Cardiology (SBHCI), SOLACI, and CRF/TVT.

This important scientific activity will take place from February 28 to March 1, 2024, at the Unique Hotel in São Paulo, Brazil, and will focus on percutaneous structural heart interventions.

This course will feature important international guests, 4 satellite symposiums, 13 edited cases, and 4 live cases. In addition, it will dive deep into the most relevant topics related to structural heart interventions.

As if that were not enough, the Call For Science for the event will feature significant prizes for the winners, including a full scholarship to attend the SOLACI-CACI 2024 Congress (airfare, lodging, and registration fees).

Don’t miss out on this opportunity and join this important scientific and educational experience!

Check the scientific program, submission guidelines, and registration requirements on the Structural Summit 2024 website.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Check out the best images of the El Salvador 2024 Sessions

Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....